Advertisement

Index by author

May 01, 1991; Volume 19,Issue 3

A

  1. Adams, L E

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

  2. Agarwal, R

    1. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
      R Agarwal, Z Y Wang, D P Bik and H Mukhtar
      Drug Metabolism and Disposition May 1991, 19 (3) 620-624;

  3. Amato, R

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  4. Anders, M W

    1. Intestinal absorption of S-(pentachlorobutadienyl)glutathione and S-(pentachlorobutadienyl)-L-cysteine, the glutathione and cysteine S-conjugates of hexachlorobuta-1,3-diene.
      Y Gietl, S Vamvakas and M W Anders
      Drug Metabolism and Disposition May 1991, 19 (3) 703-707;

B

  1. Barr, J

    1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
      L Gunawardhana, J Barr, A J Weir, K Brendel and I G Sipes
      Drug Metabolism and Disposition May 1991, 19 (3) 648-654;

  2. Bartlett, M G

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

  3. Beaune, P

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

  4. Benet, L Z

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

  5. Benowitz, N L

    1. Disposition kinetics and metabolism of nicotine-1'-N-oxide in rabbits.
      M J Duan, L Yu, C Savanapridi, P Jacob and N L Benowitz
      Drug Metabolism and Disposition May 1991, 19 (3) 667-672;

  6. Berthou, F

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

  7. Bik, D P

    1. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
      R Agarwal, Z Y Wang, D P Bik and H Mukhtar
      Drug Metabolism and Disposition May 1991, 19 (3) 620-624;

  8. Bjorge, S M

    1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
      T F Woolf, S M Bjorge, A E Black, A Holmes and T Chang
      Drug Metabolism and Disposition May 1991, 19 (3) 696-702;

  9. Black, A E

    1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
      T F Woolf, S M Bjorge, A E Black, A Holmes and T Chang
      Drug Metabolism and Disposition May 1991, 19 (3) 696-702;

  10. Blair, I A

    1. Geometric isomerization of doxepin during its N-demethylation in humans.
      H Ghabrial, C Prakash, U G Tacke, I A Blair and G R Wilkinson
      Drug Metabolism and Disposition May 1991, 19 (3) 596-599;

  11. Brendel, K

    1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
      L Gunawardhana, J Barr, A J Weir, K Brendel and I G Sipes
      Drug Metabolism and Disposition May 1991, 19 (3) 648-654;

  12. Brown, N

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  13. Brown, N K

    1. In vitro metabolism of the equatorial C11-methyl isomer of hexahydrocannabinol in several mammalian species.
      D J Harvey and N K Brown
      Drug Metabolism and Disposition May 1991, 19 (3) 714-716;

  14. Brundrett, R B

    1. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
      Z M Yuan, P B Smith, R B Brundrett, M Colvin and C Fenselau
      Drug Metabolism and Disposition May 1991, 19 (3) 625-629;

C

  1. Carpenter, H M

    1. Low dose chlordecone pretreatment altered cholesterol disposition without induction of cytochrome P-450.
      H M Carpenter and L R Curtis
      Drug Metabolism and Disposition May 1991, 19 (3) 673-678;

  2. Chan, K K

    1. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
      P S Hong and K K Chan
      Drug Metabolism and Disposition May 1991, 19 (3) 568-573;

  3. Chang, T

    1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
      T F Woolf, S M Bjorge, A E Black, A Holmes and T Chang
      Drug Metabolism and Disposition May 1991, 19 (3) 696-702;

  4. Chiou, C M

    1. Biotransformation of territrems by S9 fraction from rat liver.
      K H Ling, C M Chiou and Y L Tseng
      Drug Metabolism and Disposition May 1991, 19 (3) 587-595;

  5. Colby, H D

    1. Mechanisms responsible for the thermal sensitivity of adrenal microsomal monooxygenases.
      H D Colby, P B Johnson and M R Pope
      Drug Metabolism and Disposition May 1991, 19 (3) 679-682;

  6. Colvin, M

    1. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
      Z M Yuan, P B Smith, R B Brundrett, M Colvin and C Fenselau
      Drug Metabolism and Disposition May 1991, 19 (3) 625-629;

  7. Covington, W

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  8. Crouch, R C

    1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration.
      J L Woolley, D V Deangelis, R C Crouch, J P Shockcor and C W Sigel
      Drug Metabolism and Disposition May 1991, 19 (3) 600-608;

  9. Culver, C

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

  10. Curtis, L R

    1. Low dose chlordecone pretreatment altered cholesterol disposition without induction of cytochrome P-450.
      H M Carpenter and L R Curtis
      Drug Metabolism and Disposition May 1991, 19 (3) 673-678;

D

  1. Deangelis, D V

    1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration.
      J L Woolley, D V Deangelis, R C Crouch, J P Shockcor and C W Sigel
      Drug Metabolism and Disposition May 1991, 19 (3) 600-608;

  2. Duan, M J

    1. Disposition kinetics and metabolism of nicotine-1'-N-oxide in rabbits.
      M J Duan, L Yu, C Savanapridi, P Jacob and N L Benowitz
      Drug Metabolism and Disposition May 1991, 19 (3) 667-672;

  3. Durand, A

    1. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
      D Garrigou-Gadenne, A Durand, J P Thenot and P L Morselli
      Drug Metabolism and Disposition May 1991, 19 (3) 574-579;

E

  1. Eldadah, M K

    1. The pharmacokinetics of dobutamine in pediatric intensive care unit patients.
      P H Schwartz, M K Eldadah and C J Newth
      Drug Metabolism and Disposition May 1991, 19 (3) 614-619;

F

  1. Fenselau, C

    1. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
      Z M Yuan, P B Smith, R B Brundrett, M Colvin and C Fenselau
      Drug Metabolism and Disposition May 1991, 19 (3) 625-629;

  2. Flinois, J P

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

G

  1. Garrigou-Gadenne, D

    1. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
      D Garrigou-Gadenne, A Durand, J P Thenot and P L Morselli
      Drug Metabolism and Disposition May 1991, 19 (3) 574-579;

  2. Gek Forkert, P

    1. 1,1-Dichloroethylene elicits dose-dependent alterations in covalent binding and glutathione in murine liver.
      P Gek Forkert and M Moussa
      Drug Metabolism and Disposition May 1991, 19 (3) 580-586;

  3. Ghabrial, H

    1. Geometric isomerization of doxepin during its N-demethylation in humans.
      H Ghabrial, C Prakash, U G Tacke, I A Blair and G R Wilkinson
      Drug Metabolism and Disposition May 1991, 19 (3) 596-599;

  4. Gietl, Y

    1. Intestinal absorption of S-(pentachlorobutadienyl)glutathione and S-(pentachlorobutadienyl)-L-cysteine, the glutathione and cysteine S-conjugates of hexachlorobuta-1,3-diene.
      Y Gietl, S Vamvakas and M W Anders
      Drug Metabolism and Disposition May 1991, 19 (3) 703-707;

  5. Guengerich, F P

    1. Enantioselective hydrolysis of lorazepam 3-acetate by esterases in human and rat liver microsomes and rat brain S9 fraction.
      K Liu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 609-613;
    2. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
      X L Lu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 637-642;

  6. Guillouzo, A

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

  7. Gunawardhana, L

    1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
      L Gunawardhana, J Barr, A J Weir, K Brendel and I G Sipes
      Drug Metabolism and Disposition May 1991, 19 (3) 648-654;

  8. Gupta, S K

    1. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.
      S M Somani, S K Gupta, A Khalique and L K Unni
      Drug Metabolism and Disposition May 1991, 19 (3) 655-660;

H

  1. Harvey, D J

    1. In vitro metabolism of the equatorial C11-methyl isomer of hexahydrocannabinol in several mammalian species.
      D J Harvey and N K Brown
      Drug Metabolism and Disposition May 1991, 19 (3) 714-716;

  2. Hashimoto, S

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

  3. Hawes, E M

    1. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
      H Luo, E M Hawes, G McKay, E D Korchinski and K K Midha
      Drug Metabolism and Disposition May 1991, 19 (3) 722-724;

  4. He, X W

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

  5. Heineman, W R

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

  6. Hess, E V

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

  7. Ho, D H

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  8. Holmes, A

    1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
      T F Woolf, S M Bjorge, A E Black, A Holmes and T Chang
      Drug Metabolism and Disposition May 1991, 19 (3) 696-702;

  9. Hong, P S

    1. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
      P S Hong and K K Chan
      Drug Metabolism and Disposition May 1991, 19 (3) 568-573;

I

  1. Iwakawa, S

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

J

  1. Jacob, P

    1. Disposition kinetics and metabolism of nicotine-1'-N-oxide in rabbits.
      M J Duan, L Yu, C Savanapridi, P Jacob and N L Benowitz
      Drug Metabolism and Disposition May 1991, 19 (3) 667-672;

  2. Johnson, P B

    1. Mechanisms responsible for the thermal sensitivity of adrenal microsomal monooxygenases.
      H D Colby, P B Johnson and M R Pope
      Drug Metabolism and Disposition May 1991, 19 (3) 679-682;

K

  1. Khalique, A

    1. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.
      S M Somani, S K Gupta, A Khalique and L K Unni
      Drug Metabolism and Disposition May 1991, 19 (3) 655-660;

  2. Korchinski, E D

    1. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
      H Luo, E M Hawes, G McKay, E D Korchinski and K K Midha
      Drug Metabolism and Disposition May 1991, 19 (3) 722-724;

  3. Krakoff, I H

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

L

  1. Lin, E T

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

  2. Lin, J R

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  3. Ling, K H

    1. Biotransformation of territrems by S9 fraction from rat liver.
      K H Ling, C M Chiou and Y L Tseng
      Drug Metabolism and Disposition May 1991, 19 (3) 587-595;

  4. Liu, K

    1. Enantioselective hydrolysis of lorazepam 3-acetate by esterases in human and rat liver microsomes and rat brain S9 fraction.
      K Liu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 609-613;

  5. Lu, X L

    1. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
      X L Lu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 637-642;

  6. Luo, H

    1. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
      H Luo, E M Hawes, G McKay, E D Korchinski and K K Midha
      Drug Metabolism and Disposition May 1991, 19 (3) 722-724;

M

  1. McEuen, S F

    1. Metabolism and pharmacokinetics of 1,3-dinitrobenzene in the rat and the hamster.
      S F McEuen and M G Miller
      Drug Metabolism and Disposition May 1991, 19 (3) 661-666;

  2. McKay, G

    1. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
      H Luo, E M Hawes, G McKay, E D Korchinski and K K Midha
      Drug Metabolism and Disposition May 1991, 19 (3) 722-724;

  3. Midha, K K

    1. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
      H Luo, E M Hawes, G McKay, E D Korchinski and K K Midha
      Drug Metabolism and Disposition May 1991, 19 (3) 722-724;

  4. Miller, M G

    1. Metabolism and pharmacokinetics of 1,3-dinitrobenzene in the rat and the hamster.
      S F McEuen and M G Miller
      Drug Metabolism and Disposition May 1991, 19 (3) 661-666;

  5. Mongey, A B

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

  6. Morselli, P L

    1. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
      D Garrigou-Gadenne, A Durand, J P Thenot and P L Morselli
      Drug Metabolism and Disposition May 1991, 19 (3) 574-579;

  7. Moussa, M

    1. 1,1-Dichloroethylene elicits dose-dependent alterations in covalent binding and glutathione in murine liver.
      P Gek Forkert and M Moussa
      Drug Metabolism and Disposition May 1991, 19 (3) 580-586;

  8. Mukhtar, H

    1. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
      R Agarwal, Z Y Wang, D P Bik and H Mukhtar
      Drug Metabolism and Disposition May 1991, 19 (3) 620-624;

N

  1. Newman, R A

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  2. Newth, C J

    1. The pharmacokinetics of dobutamine in pediatric intensive care unit patients.
      P H Schwartz, M K Eldadah and C J Newth
      Drug Metabolism and Disposition May 1991, 19 (3) 614-619;

O

  1. Owens, S M

    1. Chronic administration of phencyclidine: pharmacokinetic comparison of intravenous and subcutaneous infusions in Sprague-Dawley rats.
      W D Wessinger and S M Owens
      Drug Metabolism and Disposition May 1991, 19 (3) 719-721;

P

  1. Pope, M R

    1. Mechanisms responsible for the thermal sensitivity of adrenal microsomal monooxygenases.
      H D Colby, P B Johnson and M R Pope
      Drug Metabolism and Disposition May 1991, 19 (3) 679-682;

  2. Prakash, C

    1. Geometric isomerization of doxepin during its N-demethylation in humans.
      H Ghabrial, C Prakash, U G Tacke, I A Blair and G R Wilkinson
      Drug Metabolism and Disposition May 1991, 19 (3) 596-599;

R

  1. Raber, M

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  2. Ratanasavanh, D

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

  3. Remmel, R P

    1. A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. In vitro and in vivo studies.
      R P Remmel and M W Sinz
      Drug Metabolism and Disposition May 1991, 19 (3) 630-636;

  4. Riche, C

    1. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
      F Berthou, J P Flinois, D Ratanasavanh, P Beaune, C Riche and A Guillouzo
      Drug Metabolism and Disposition May 1991, 19 (3) 561-567;

  5. Roberts, S M

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

S

  1. Sanders, R A

    1. Comparative study of phase II biotransformation in rabbit ocular tissues.
      J B Watkins, D P Wirthwein and R A Sanders
      Drug Metabolism and Disposition May 1991, 19 (3) 708-713;

  2. Savanapridi, C

    1. Disposition kinetics and metabolism of nicotine-1'-N-oxide in rabbits.
      M J Duan, L Yu, C Savanapridi, P Jacob and N L Benowitz
      Drug Metabolism and Disposition May 1991, 19 (3) 667-672;

  3. Schmidt, S

    1. Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
      D H Ho, N Brown, J R Lin, W Covington, R A Newman, M Raber, R Amato, S Schmidt and I H Krakoff
      Drug Metabolism and Disposition May 1991, 19 (3) 643-647;

  4. Schwartz, P H

    1. The pharmacokinetics of dobutamine in pediatric intensive care unit patients.
      P H Schwartz, M K Eldadah and C J Newth
      Drug Metabolism and Disposition May 1991, 19 (3) 614-619;

  5. Shockcor, J P

    1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration.
      J L Woolley, D V Deangelis, R C Crouch, J P Shockcor and C W Sigel
      Drug Metabolism and Disposition May 1991, 19 (3) 600-608;

  6. Sigel, C W

    1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration.
      J L Woolley, D V Deangelis, R C Crouch, J P Shockcor and C W Sigel
      Drug Metabolism and Disposition May 1991, 19 (3) 600-608;

  7. Sinz, M W

    1. A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. In vitro and in vivo studies.
      R P Remmel and M W Sinz
      Drug Metabolism and Disposition May 1991, 19 (3) 630-636;

  8. Sipes, I G

    1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
      L Gunawardhana, J Barr, A J Weir, K Brendel and I G Sipes
      Drug Metabolism and Disposition May 1991, 19 (3) 648-654;

  9. Smith, P B

    1. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
      Z M Yuan, P B Smith, R B Brundrett, M Colvin and C Fenselau
      Drug Metabolism and Disposition May 1991, 19 (3) 625-629;

  10. Somani, S M

    1. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.
      S M Somani, S K Gupta, A Khalique and L K Unni
      Drug Metabolism and Disposition May 1991, 19 (3) 655-660;

  11. Swaisgood, H

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

T

  1. Tacke, U G

    1. Geometric isomerization of doxepin during its N-demethylation in humans.
      H Ghabrial, C Prakash, U G Tacke, I A Blair and G R Wilkinson
      Drug Metabolism and Disposition May 1991, 19 (3) 596-599;

  2. Thenot, J P

    1. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
      D Garrigou-Gadenne, A Durand, J P Thenot and P L Morselli
      Drug Metabolism and Disposition May 1991, 19 (3) 574-579;

  3. Tseng, Y L

    1. Biotransformation of territrems by S9 fraction from rat liver.
      K H Ling, C M Chiou and Y L Tseng
      Drug Metabolism and Disposition May 1991, 19 (3) 587-595;

  4. Tsou, Y H

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

U

  1. Unger, S E

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

  2. Unni, L K

    1. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.
      S M Somani, S K Gupta, A Khalique and L K Unni
      Drug Metabolism and Disposition May 1991, 19 (3) 655-660;

V

  1. Vamvakas, S

    1. Intestinal absorption of S-(pentachlorobutadienyl)glutathione and S-(pentachlorobutadienyl)-L-cysteine, the glutathione and cysteine S-conjugates of hexachlorobuta-1,3-diene.
      Y Gietl, S Vamvakas and M W Anders
      Drug Metabolism and Disposition May 1991, 19 (3) 703-707;

  2. Van Breemen, R B

    1. Degradation of peptide drugs by immobilized digestive proteases.
      R B Van Breemen, M G Bartlett, Y H Tsou, C Culver, H Swaisgood and S E Unger
      Drug Metabolism and Disposition May 1991, 19 (3) 683-690;

  3. Volland, C

    1. Stereoselective disposition of ketoprofen in rats.
      S Iwakawa, X W He, S Hashimoto, C Volland, L Z Benet and E T Lin
      Drug Metabolism and Disposition May 1991, 19 (3) 717-718;

W

  1. Wang, Z Y

    1. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
      R Agarwal, Z Y Wang, D P Bik and H Mukhtar
      Drug Metabolism and Disposition May 1991, 19 (3) 620-624;

  2. Watkins, J B

    1. Comparative study of phase II biotransformation in rabbit ocular tissues.
      J B Watkins, D P Wirthwein and R A Sanders
      Drug Metabolism and Disposition May 1991, 19 (3) 708-713;

  3. Weir, A J

    1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
      L Gunawardhana, J Barr, A J Weir, K Brendel and I G Sipes
      Drug Metabolism and Disposition May 1991, 19 (3) 648-654;

  4. Wessinger, W D

    1. Chronic administration of phencyclidine: pharmacokinetic comparison of intravenous and subcutaneous infusions in Sprague-Dawley rats.
      W D Wessinger and S M Owens
      Drug Metabolism and Disposition May 1991, 19 (3) 719-721;

  5. Wheeler, J F

    1. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
      J F Wheeler, L E Adams, A B Mongey, S M Roberts, W R Heineman and E V Hess
      Drug Metabolism and Disposition May 1991, 19 (3) 691-695;

  6. Wilkinson, G R

    1. Geometric isomerization of doxepin during its N-demethylation in humans.
      H Ghabrial, C Prakash, U G Tacke, I A Blair and G R Wilkinson
      Drug Metabolism and Disposition May 1991, 19 (3) 596-599;

  7. Wirthwein, D P

    1. Comparative study of phase II biotransformation in rabbit ocular tissues.
      J B Watkins, D P Wirthwein and R A Sanders
      Drug Metabolism and Disposition May 1991, 19 (3) 708-713;

  8. Woolf, T F

    1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
      T F Woolf, S M Bjorge, A E Black, A Holmes and T Chang
      Drug Metabolism and Disposition May 1991, 19 (3) 696-702;

  9. Woolley, J L

    1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration.
      J L Woolley, D V Deangelis, R C Crouch, J P Shockcor and C W Sigel
      Drug Metabolism and Disposition May 1991, 19 (3) 600-608;

Y

  1. Yang, S K

    1. Enantioselective hydrolysis of lorazepam 3-acetate by esterases in human and rat liver microsomes and rat brain S9 fraction.
      K Liu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 609-613;
    2. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
      X L Lu, F P Guengerich and S K Yang
      Drug Metabolism and Disposition May 1991, 19 (3) 637-642;

  2. Yu, L

    1. Disposition kinetics and metabolism of nicotine-1'-N-oxide in rabbits.
      M J Duan, L Yu, C Savanapridi, P Jacob and N L Benowitz
      Drug Metabolism and Disposition May 1991, 19 (3) 667-672;

  3. Yuan, Z M

    1. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
      Z M Yuan, P B Smith, R B Brundrett, M Colvin and C Fenselau
      Drug Metabolism and Disposition May 1991, 19 (3) 625-629;
Back to top

In this issue

Advertisement